Publications by authors named "Julia FaSSbender"

Claim this Profile
N
Novel fully human high-affinity anti-TREM2 antibody shows efficacy in clinically relevant Alzheimer´s mouse model.
Markus Kraller, Julia Faßbender, Ammar Jabali, Joseph Kroeger, Barbara Fink

Alzheimers Res Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue block staining and domestic adhesive tape yield qualified integral sections of adult mouse orbits and eyeballs.
Zhongmin Li, Martin Ungerer, Julia Faßbender, Clara Wenhart, Hans-Peter Holthoff

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine /collagen content in a long-term Graves' disease mouse model.
Tanja Diana, Martin Ungerer, Christian Wüster, Julia Faßbender, Zhongmin Li

J Autoimmun· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fructosylated peptide derived from a collagen II T cell epitope for long-term treatment of arthritis (FIA-CIA) in mice.
Clara Wenhart, Hans-Peter Holthoff, Andreas Reimann, Zhongmin Li, Julia Faßbender

Sci Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Long-Term Graves' Disease Animal Model Confirmed by Functional Thyrotropin Receptor Antibodies.
Tanja Diana, Hans-Peter Holthoff, Julia Fassbender, Christian Wüster, Michael Kanitz

Eur Thyroid J· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic Effects of Short Cyclic and Combined Epitope Peptides in a Long-Term Model of Graves' Disease and Orbitopathy.
Julia Faßbender, Hans-Peter Holthoff, Zhongmin Li, Martin Ungerer

Thyroid· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclic Peptides for Effective Treatment in a Long-Term Model of Graves Disease and Orbitopathy in Female Mice.
Hans-Peter Holthoff, Zhongmin Li, Julia Faßbender, Andreas Reimann, Kristin Adler

Endocrinology· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.
Heidrun Degen, Oliver Borst, Melanie Ziegler, Ann-Katrin Mojica Munoz, Janina Jamasbi, Julia Fassbender

J Am Heart Assoc· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of Mouse Models of Graves' Disease and Orbitopathy-Novel Treatment by Induction of Tolerance.
Martin Ungerer, Julia Faßbender, Zhongmin Li, Götz Münch, Hans-Peter Holthoff

Clin Rev Allergy Immunol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined administration of the GPVI-Fc fusion protein Revacept with low-dose thrombolysis in the treatment of stroke.
Andreas Reimann, Zhongmin Li, Silvia Goebel, Julia Fassbender, Hans-Peter Holthoff

Heart Int· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged TSH receptor A subunit immunization of female mice leads to a long-term model of Graves' disease, tachycardia, and cardiac hypertrophy.
Hans-Peter Holthoff, Sylvia Goebel, Zhongmin Li, Julia Faßbender, Andreas Reimann

Endocrinology· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis